Newly Diagnosed Multiple Myeloma is Associated with Hypercoagulablity and High Risk of VTE. The Roadmap Study

被引：0
|
作者：
Fotiou, Despina [1 ]
Gerotziafas, Grigorios [2 ]
Zagouri, Flora [3 ]
Sergentanis, Theodoros [3 ]
机构：
[1] Alexandra Hosp, Oncol & Hematol Dept, Athens, Greece
[2] Tenon Univ Hosp, Fac Med Pierre Marie Curie, Serv Hematol Biol, Paris, France
[3] Natl & Kapodistrian Univ Athens, Dept Clin Therapeut, Athens, Greece
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 01期
关键词：
D O I：
10.1016/j.clml.2017.03.174
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS-172
引用
收藏
页码：E97 / E97
页数：1
相关论文
共 50 条
  • [1] Treatment Resistance Risk in Patients with Newly Diagnosed Multiple Myeloma Is Associated with Blood Hypercoagulability: The ROADMAP-MM Study
    Gerotziafas, Grigorios T.
    Fotiou, Despina
    Sergentanis, Theodoros N.
    Papageorgiou, Loula
    Fareed, Jawed
    Falanga, Anna
    Sabbah, Michele
    Garderet, Laurent
    Terpos, Evangelos
    Elalamy, Ismail
    Van Dreden, Patrick
    Dimopoulos, Meletios A.
    HEMATO, 2022, 3 (01): : 188 - 203
  • [2] External Validation of the Impede VTE Risk Score in Newly Diagnosed Multiple Myeloma (MM) Patients
    Covut, Fahrettin
    Ahmed, Ramsha
    Samaras, Christy J.
    Anwer, Faiz
    Garcia, Alex V. Mejia
    Angelini, Dana E.
    Faiman, Beth M.
    Reed, Janice
    Karam, Mary Ann
    Schlueter, Kristen
    Mathur, Saveta
    Hamilton, Kimberly
    Rosko, Nathaniel
    Valent, Jason
    Khouri, Jack
    BLOOD, 2019, 134
  • [3] Real World Validation of VTE Risk Models in Newly Diagnosed Multiple Myeloma in a Community Setting
    Kapur, Shivani
    Feehan, Kayla
    Mosiman, Samuel
    Frankki, Susan
    Rosenstein, Lori j
    BLOOD, 2021, 138
  • [4] Individualized risk in newly diagnosed multiple myeloma
    Maura, Francesco
    Rajanna, Arjun
    Ziccheddu, Bachisio
    Derkach, Andriy
    Poos, Alexandra
    Maclachlan, Kylee
    Boyle, Eileen
    Hultcrantz, Malin
    Silva, Ariosto
    Jackson, Graham
    Kaiser, Martin
    Pawlyn, Charlotte
    Cook, Gordon
    Bergsagel, Leif
    Goldschmidt, Hartmut
    Weisel, Katja
    Fenk, Roland
    Mai, Elias
    Raab, Marc
    van Rhee, Frits
    Usmani, Saad
    Shain, Ken
    Weinhold, Niels
    Morgan, Gareth
    Landgren, Ola
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S236 - S236
  • [5] Individualized risk stratification in newly diagnosed multiple myeloma
    Rajanna, Arjun Raj
    Maura, Francesco
    Derkach, Andriy
    Ziccheddu, Bachisio
    Weinhold, Niels
    Maclachlan, Kylee
    Diamond, Benjamin
    Davies, Faith
    Boyle, Eileen
    Walker, Brian
    Pos, Alexandra
    Hulcrantz, Malin
    Silva, Ariosto
    Hampton, Oliver
    Teer, Jamie K.
    Bolli, Niccolo
    Jackson, Graham
    Kaiser, Martin
    Pawlyn, Charlotte
    Cook, Gordon
    Verducci, Dennis
    Kazandjian, Dickran
    Van Rhee, Fritz
    Usmani, Saad
    Shain, Kenneth H.
    Raab, Marc S.
    Morgan, Gareth
    Landgren, Ola
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Presence of Multiple High Risk Cytogenetic Abnormalities Is Associated with Rapid Progression and Shorter Survival in Newly Diagnosed Multiple Myeloma
    Smallbone, Portia
    Clugston, Stephanie
    De Kraa, Rebecca
    Purtill, Duncan
    Wright, Matthew
    Leahy, Michael F.
    Sidiqi, M. Hasib
    BLOOD, 2020, 136
  • [7] Risk of stroke in patients with newly diagnosed multiple myeloma: a retrospective cohort study
    Lee, Gin-Yi
    Lee, Yu-Ting
    Yeh, Chiu-Mei
    Hsu, Pei
    Lin, Ting-Wei
    Gau, Jyh-Pyng
    Yu, Yuan-Bin
    Hsiao, Liang-Tsai
    Tzeng, Cheng-Hwai
    Chiou, Tzeon-Jye
    Liu, Jin-Hwang
    Liu, Yao-Chung
    Liu, Chia-Jen
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (04) : 726 - 733
  • [8] Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma
    Geng, Chuanying
    Yang, Guangzhong
    Zhou, Huixing
    Wang, Huijuan
    Li, Yanchen
    Leng, Yun
    Zhang, Zhiyao
    Jian, Yuan
    Chen, Wenming
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (04):
  • [9] Current Approach to Managing Patients with Newly Diagnosed High-Risk Multiple Myeloma
    Naimisha Marneni
    Rajshekhar Chakraborty
    Current Hematologic Malignancy Reports, 2021, 16 : 148 - 161
  • [10] Caution With Routine Use of Daratumumab for Newly Diagnosed High-Risk Multiple Myeloma
    Mohyuddin, Ghulam Rehman
    Abdallah, Al-Ola
    McClune, Brian
    JAMA ONCOLOGY, 2021, 7 (04) : 635 - 635
12345